KEEGO HARBOR, Mich.–(BUSINESS WIRE)–ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (“ZIVO” or the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces that Chairman of the Board John B. Payne has been named President and Chief Executive Officer of the Company. Mr. […]
The post ZIVO Bioscience Names Chairman John B. Payne as President and CEO appeared first on Fintech News.